Literature DB >> 9393847

Splicing into senescence: the curious case of p16 and p19ARF.

D A Haber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9393847     DOI： 10.1016/s0092-8674(00)80441-9

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  31 in total

1.  Role of p14(ARF) in replicative and induced senescence of human fibroblasts.

Authors:  W Wei; R M Hemmer; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.

Authors:  Sushil G Rane; Stephen C Cosenza; Richard V Mettus; E Premkumar Reddy
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 3.  Cell cycle exit: growth arrest, apoptosis, and tumor suppression revisited.

Authors:  L Philipson
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

4.  INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

Authors:  C A Schmitt; M E McCurrach; E de Stanchina; R R Wallace-Brodeur; S W Lowe
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

5.  Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).

Authors:  M Malumbres; I Pérez De Castro; M I Hernández; M Jiménez; T Corral; A Pellicer
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).

Authors:  J Mitra; C Y Dai; K Somasundaram; W S El-Deiry; K Satyamoorthy; M Herlyn; G H Enders
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

7.  Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas.

Authors:  Agustí Alentorn; Caroline Dehais; François Ducray; Catherine Carpentier; Karima Mokhtari; Dominique Figarella-Branger; Olivier Chinot; Elisabeth Cohen-Moyal; Carole Ramirez; Hugues Loiseau; Selma Elouahdani-Hamdi; Patrick Beauchesne; Olivier Langlois; Christine Desenclos; Jean-Sébastien Guillamo; Phong Dam-Hieu; François Ghiringhelli; Philippe Colin; Joel Godard; Fabrice Parker; Frédéric Dhermain; Antoine F Carpentier; Jean-Sebastien Frenel; Philippe Menei; Luc Bauchet; Thierry Faillot; Mélanie Fesneau; Denys Fontaine; Marie-Jeannette Motuo-Fotso; Elodie Vauleon; Claude Gaultier; Caroline Le Guerinel; Edouard-Marcel Gueye; Georges Noel; Nicolas Desse; Xavier Durando; Eduardo Barrascout; Michel Wager; Damien Ricard; Ioana Carpiuc; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Neurology       Date:  2015-09-18       Impact factor: 9.910

Review 8.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

9.  Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.

Authors:  V G Gorgoulis; P Zacharatos; A Kotsinas; T Liloglou; A Kyroudi; M Veslemes; A Rassidakis; T D Halazonetis; J K Field; C Kittas
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

10.  The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53.

Authors:  K D Robertson; P A Jones
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.